Objective Hypoglycemia is a cause of significant morbidity among patients with diabetes and may be associated with greater risk of death. We conducted a retrospective study to determine whether ...
The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.
Hypoglycemia unawareness is when a person cannot recognize that they are experiencing an episode of low blood sugar. This can result in them losing consciousness or contribute to long-term health ...
Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...
New research published in Endocrine revealed findings that may contribute to preventing erectile dysfunction in men with type ...
Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.
“Continuous glucose monitors with low-glucose alerts can potentially reduce the risk of hypoglycemia for insulin-treated ...
The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback